Articles tagged with Kidney
A meta-analysis of 11 trials involving 78,607 patients found a 9% reduction in major adverse cardiovascular events (MACE) and a 14% reduction in cardiovascular death with SGLT2 inhibitors. The analysis showed consistent effects across patient groups and subgroups.
Researchers have shown that a single normal copy of a defective gene can prevent cysts in polycystic kidney disease. Additionally, they found that a type of drug called a glycoside can sidestep the effects of the defective gene and prevent cyst formation.
A study found that structural racism is largely to blame for disparities in tuberculosis (TB) incidence among the U.S.-born population. Researchers analyzed national TB registry data and found that TB incidence ratios were higher for certain racial and ethnic groups, with greater relative disparities among females.
A new machine learning tool, PO-AKID-teller, can accurately predict patients at risk of acute kidney injury requiring dialysis after aortic dissection surgery. The model provides an interpretable explanation of the predicted risk, enabling clinicians to make informed decisions.
A systematic review of 35 years of medical literature finds that poverty is the primary reason people sell their kidneys, while lack of information, debt, and altruism also contribute. Regional variation exists, with poverty being the main driver in the Indian Subcontinent and brokers playing a significant role in other countries.
Researchers created a risk prediction model using patient data from six major US cancer centers. The model found that patients with high blood pressure, diabetes, and lower magnesium levels were at highest risk of moderate-to-severe kidney injury. The tool can help clinicians and patients make informed decisions about cisplatin treatment.
Researchers identified the WWP2 gene as crucial for regulating energy supply to cells responsible for renal failure. Inhibiting this gene may slow kidney damage and halt disease progression.
A recent study in Florida found that nearly all farm workers were dehydrated at the end of their shifts and more than half remained dehydrated the following morning. The researchers emphasized the need for stricter federal regulations and smaller interventions to address this issue.
A five-day course of inorganic nitrate significantly reduces contrast-induced nephropathy rates, improves three-month renal function, and lowers one-year major adverse cardiac events. The trial also shows improved kidney outcomes at three months compared to placebo.
Research highlights new findings on social vulnerability and survivorship after colorectal cancer resection, as well as disparities in kidney recovery among Black donors. Additionally, studies reveal cost savings from implementing quality interventions and explore eligibility for transplants in obese patients with end-stage renal disease.
A study by Linköping University found that a daily intake of liquorice containing 100mg glycyrrhizic acid raised blood pressure by an average of 3.1mmHg in young healthy people. This effect was seen in all participants, but the most sensitive individuals showed increased fluid volume and heart workload.
A collaborative study found that patients with end-stage renal disease who undergo weight loss surgery can experience significant improvements in BMI, hypertension, and diabetes management. This enhancement of overall health and transplant viability offers hope for previously ineligible patients.
A U.S.-Canadian research collaboration identified common blood changes as a risk factor for acute kidney injury (AKI) in over 1 in 5 hospitalized adults. The discovery may lead to new, more effective treatments for AKI and prevent its progression to end-stage renal disease.
A new study found that dialysis facilities serving high-risk populations are more likely to receive lower reimbursement under the End-Stage Renal Disease Treatment Choices Model. The rate of home dialysis and transplant waitlisting is also lower among these facilities.
Researchers at Johns Hopkins Medicine have reported promising results from a clinical trial testing a novel immunotherapy combination to target advanced, potentially lethal skin cancers in kidney transplant patients. Two out of six patients experienced complete tumor regression after adding a second checkpoint inhibitor to the regimen.
A team of researchers from Aarhus University has developed a simple measurement of protein in the urine that can predict which individuals are at high risk of rapid progression of chronic kidney disease. The study found that patients with newly diagnosed mild to moderate chronic kidney disease within three years have a 15% risk of rapi...
Researchers analyzed tissue and fecal samples from 90 stranded marine mammals to study the distribution of toxic elements. The study found that Risso's dolphins and short-finned pilot whales had high concentrations of mercury, cadmium, and lead, while dwarf sperm whales had low levels.
Segregated neighborhoods contribute to racial disparities in live donor kidney transplantation. Targeted interventions, such as community outreach clinics, can help mitigate these effects and promote equitable access.
A recent study found that a commercial machine learning tool was moderately successful in predicting hospitalization-related kidney injury, but struggled to identify high-risk patients. The tool performed better for low-risk patients and Stage 1 HA-AKI cases.
Researchers developed a high-speed modulation system combining digital display with super-resolution imaging, significantly improving lateral and axial resolution. This enables detailed study of subcellular structures in animal cells and plant ultrastructures, paving the way for future biological discoveries.
A recent analysis of the AWAKEN study data found that repeat episodes of acute kidney injury in hospitalized infants do not increase the risk of death but can extend hospitalization. The study suggests that initial AKI is already dangerous and long-term effects are still under investigation.
Research found that boosting weekly total physical activity by just over an hour is associated with a 33% lower risk of progression to chronic kidney disease. The study also showed that longer bouts of moderate-intensity exercise, even those below 10 minutes, contribute to better outcomes.
Researchers found that SGLT2 inhibitors reduced kidney stone rates by 30% compared to GLP1 agonists and 25% compared to DPP4 inhibitors. The study included data from 716,406 adults with type 2 diabetes who took these medications.
A study of over 1.6 million ED visits found that nearly two-thirds of low-risk pulmonary embolism patients were hospitalized, despite evidence suggesting safety in outpatient management. Researchers suggest further investigation into ED triage decisions to improve appropriate use of outpatient care.
Researchers found combining common immune-suppressing drugs with a complement inhibitor effectively managed the initial human immune response against transplanted pig kidneys. The regimen, which relies solely on already FDA-approved medications, showed remarkable success in Parsons model case series.
A survey study found a lower rate of overall fractures among living kidney donors, yet an increased incidence of vertebral fractures after 25 years following donation. Treatment with dietary supplements may help alleviate these issues and patient morbidity.
A recent study found that exposure to multiple toxicants across generations can amplify health problems, such as obesity and kidney diseases. The study, published in Environmental Epigenetics, showed that epigenetic changes were greatly altered with each new generation of exposed animals.
Regular NHS Health Checks are associated with reduced risks of dying and developing long-term diseases like dementia and liver cirrhosis. The study analyzed data from 97,204 UK Biobank participants and found that attendees had lower diagnosis rates for these conditions, including a 19% lower rate of dementia diagnosis.
Researchers develop compound that reduces size of kidney cysts and improves kidney function in mouse models of ADPKD. The compound, originally designed to treat cancer, works by exploiting kidney cyst cells' vulnerability to oxidative stress.
Researchers developed an AI-driven algorithm that accurately predicts death and complications after percutaneous coronary intervention (PCI). The tool uses patient feedback to provide a patient-centered, individualized risk prediction score.
Chronic kidney disease and cardiovascular disease significantly worsen prognosis for severely burned patients. The study analyzed data from 1,193 patients and found that nearly half did not survive their burns with impaired kidney function. Researchers highlight the need to integrate these findings into burn treatment scores.
High adolescent BMI significantly increases the risk of developing early chronic kidney disease in young adulthood, according to a recent study published in JAMA Pediatrics. Researchers emphasize the need for preventive measures and management of risk factors associated with CKD in adolescents with elevated BMI.
A Learning Health System model is being developed to increase organ donation and reduce disparities in access to transplantation. The project, led by Hennepin Healthcare Research Institute, will use data tools to track progress and improve equity in organ donation across the US.
Researchers from Osaka University have discovered a link between the rare D-form of the amino acid alanine and the circadian clock's influence on glucose metabolism in the kidney. The study found that D-alanine regulates gluconeogenesis, a process that creates new glucose to maintain energy levels, and is mediated by the protein Cry2.
A recent study found that alterations in the human microbiome, including those in the gut, urinary, and salivary tracts, are linked to kidney stone formation. The research team discovered changes in these microbiomes were common among patients with kidney stones.
A study of 57,000 adults reveals racial disparities in access to living donor kidney transplants, highlighting the need for targeted interventions. The findings emphasize the importance of addressing systemic inequalities in transplant programs and centers.
A clinical trial found that an experimental drug, BI 690517, reduced albuminuria in 70% of patients when paired with a standard-care medication. The study also showed that the combination of the two drugs mitigated the risk of hyperkalemia.
Researchers at Johns Hopkins Medicine have identified six protein markers that can predict and manage acute kidney injury (AKI), a condition marked by serious inflammation. The study's findings offer hope for non-invasive assessments of AKI, potentially reducing the need for invasive kidney biopsies.
A study found childhood cancer survivors have twice the risk of developing prediabetes as the general public, increasing their risk of life-threatening diseases. Lifestyle interventions may help reduce this risk and improve their life expectancy.
A new study found that a genetic variant in the APOL1 gene reduces the risk of kidney disease in high-risk individuals, particularly those with African ancestry. The discovery may lead to reclassification of patients and expansion of potential kidney donors.
Researchers from Tokyo Medical and Dental University found that people admitted to the hospital for acute hypertension are increasingly likely to need urgent kidney dialysis or die in the hospital. The study's lead author notes that patients with certain traits, such as being younger, male, or overweight, are high-risk groups.
The American College of Physicians has published a new clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus in chronic kidney disease. The guideline includes recommendations for expanding treatment with sofosbuvir-based regimens to patients with CKD glomerular filtration rate categor...
Researchers have identified the genetic defect causing infantile cystinosis, a rare disease that shortens lifespan, and developed a protocol to differentiate stem cells into healthy kidney cells. The study suggests using CRISPR genome editing to repair the defective gene and potentially cure the disease.
Researchers at Monash University have discovered how anti-obesity drugs like Ozempic interact with the RAGE receptor to control kidney damage in diabetes. This finding opens up new therapeutic drug targets for preventing kidney disease in people with diabetes.
Research suggests visfatin stimulates membrane raft clustering, leading to NLRP3 inflammasome activation and podocyte injury. The study highlights the role of membrane raft redox signaling in visfatin-induced inflammation and kidney damage.
Researchers used 3D eye scans to detect changes in the retina and monitor kidney health, finding that thinner retinas correlated with declining kidney function. The technology has potential to support early diagnosis and aid lifestyle changes to reduce health complications.
According to a new study published in Annals of Internal Medicine, most adults who qualify for statin use for primary prevention are not receiving them. The study found that despite increased overall statin use over time, only 35% of eligible adults were taking statins between 2013 and 2018. The researchers suggest that innovative effo...
Researchers have developed a new mixture, organ agar, that enables them to screen bacteria more efficiently than traditional methods. This innovation allows for the testing of over 1,700 mutants of the UTI-causing bacteria Proteus mirabilis using only a quarter of the mice typically required.
A new Vanderbilt University Medical Center study found that thiazide diuretics were associated with a 15% lower risk of kidney stones. Higher serum calcium levels also linked to thiazides, supporting the notion that they affect kidney stone risk by modulating calcium excretion.
A randomized trial found that unfiltered traffic-related air pollution caused a rapid and significant increase in blood pressure, which persisted for more than 24 hours. The study suggests that effective cabin air filtration may reduce the negative effects of air pollution on blood pressure.
Patients with heart failure treated with dapagliflozin experienced frequent initial estimated glomerular filtration rate declines, but without increased cardiovascular or kidney event risks. The study suggests that sodium-glucose cotransporter-2 inhibitors can be safely continued in patients experiencing eGFR decline.
Treatment with obinutuzumab has been shown to preserve kidney function and prevent flares in patients with lupus nephritis. The addition of obinutuzumab to standard treatment reduced the risk of composite outcomes, such as death or treatment failure, by 60%.
A clinical study found that a ketogenic diet can improve kidney function in patients with hereditary polycystic kidney disease. After three months, positive changes were seen in key parameters, with no unexpected side effects.
Men who are overweight or obese at age 18 have a higher risk of developing 17 different cancers later in life. Higher BMI is also associated with an increased risk of mortality after cancer diagnosis for certain types of cancer.
A real-world analysis of 3,450 kidney transplant patients treated with SGLT2 inhibitors found significant reductions in kidney transplant rejection (59% less likely), kidney transplant failure (33% less likely), major adverse cardiac events (40% less likely), and mortality risk (44% less likely) over a 3-year period.
A novel multicomponent intervention aimed at improving patient access to kidney transplants did not significantly increase the rate of completed steps in a randomized clinical trial involving 20,375 patients. The study highlights the need for sustained efforts to address barriers to transplantation globally.
Sotagliflozin, a dual SGLT1 and 2 inhibitor, has been shown to reduce the risk of sustained decline in estimated glomerular filtration rate and cardiorenal composites by 38% and 23%, respectively. The findings support previously reported benefits of sotagliflozin in reducing cardiovascular events.
Results from high-impact clinical trials will be presented at ASN Kidney Week 2023, offering potential improvements in kidney-related medical care. The trials bring together leading experts and professionals to exchange knowledge and discuss the latest advances.
Researchers found a positive association between elevated urinary albumin and sub-clinical coronary artery pathology, including microcalcifications, in individuals with type 2 diabetes without symptoms of cardiovascular disease. Microcalcification activity was higher in those with albuminuria, indicating potential kidney damage.
Researchers discovered that patients with FSGS who received sparsentan treatment experienced improved kidney function and reduced proteinuria, a key indicator of kidney damage. The study suggests sparsentan may be a potential new treatment option for the disorder, offering hope for patients affected by FSGS.